PLAT and carotid artery occlusion: For a “human equivalent” tPA dose, our study indicates that a 2x clinical dose (1.8 mg/kg) in this model with 17% recanalization rates best reflects clinical recanalization of carotid artery occlusion for which clinical rates are between 10–30%2, 3.